WEF Clinical, founded by ALS researcher Dr. Wilbert E. Frank, is a full-service Clinical Research Organization offering comprehensive services including project management, site management, clinical monitoring, and data management for pharmaceutical companies, supporting Phase I-IV clinical trials with meticulous execution and compliance.
Founded in 1989 by Dr. Wilbert E. Frank, a visionary clinical researcher with a PhD in Medicine and Pharmacy, WEF Clinical has established itself as a cornerstone in the field of clinical research
Founded in 1989 by Dr. Wilbert E. Frank, a visionary clinical researcher with a PhD in Medicine and Pharmacy. WEF Clinical has established itself as a cornerstone in the field of clinical research. Headquartered in Romania, the company was born out of Dr. Frank’s passion for advancing medical science, particularly in areas that challenge conventional understanding.
From its inception, WEF Clinical has maintained a relentless focus on the study of ALS (Amyotrophic Lateral Sclerosis), a devastating neurodegenerative disease that has eluded a cure for decades. Dr Frank’s early recognition of the critical need for specialized research in this area laid the foundation for the company’s future endeavours. Over the years, WEF Clinical has not only contributed to the global body of knowledge on ALS but has also influenced the direction of research, treatment approaches, and policy-making in the field.
The company’s work in ALS research is marked by a commitment to innovation, collaboration, and the rigorous pursuit of scientific excellence. WEF Clinical has been instrumental in numerous groundbreaking studies, contributing valuable insights that have shaped the current understanding of the disease. Through strategic partnerships, extensive clinical trials, and a dedication to exploring novel therapeutic avenues, WEF Clinical has become a beacon of hope for patients and families affected by ALS.
As a leader in ALS research, WEF Clinical continues to push the boundaries of what is known about the disease, striving to bring the world closer to finding a cure. Dr. Wilbert E. Frank’s legacy lives on through the company’s ongoing mission to combat ALS and improve the lives of those who suffer from this challenging condition.
